Combined Arm-leg Ergometer Endurance Training Versus Cycle Ergometer Endurance Training in Myocar… (NCT07645040) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Combined Arm-leg Ergometer Endurance Training Versus Cycle Ergometer Endurance Training in Myocardial Infarction
40 participantsStarted 2026-06
Plain-language summary
Myocardial infarction (MI) often leads to reduced cardiorespiratory fitness, poor exercise tolerance, and decreased quality of life. Conventional rehabilitation mainly uses cycle ergometer training but may not adequately improve upper-limb function needed for daily activities. This randomized clinical trial aims to compare the effects of combined arm-leg ergometer endurance training and cycle ergometer training on cardiorespiratory fitness, exercise tolerance, and quality of life in post-MI patients. The study will be conducted in cardiac rehabilitation centers in Pakistan using 40 medically stable post-MI patients divided into two groups. Group A will receive combined arm-leg ergometer training, while Group B will receive cycle ergometer training. Sessions will be conducted 3 times weekly for 6 weeks. Outcomes will be measured using VO₂ peak, 6-minute walk test, and MacNew HRQOL questionnaire, with data analyzed through SPSS version 25.
Who can participate
Age range
40 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Males and Females
* Patients with a history of myocardial infarction (MI)
* Medically stable for at least 1 month post-MI
* Age between 40-70 years.
* Willingness and ability to participate in exercise training.
* Medically cleared for exercise by a cardiologist.
Exclusion Criteria:
* Unstable angina or uncontrolled hypertension.
* Orthopedic/neurological limitations affecting participants.
* Arrhythmias
* Fever
* Cognitive impairment or non-consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial hasn't started recruiting yet, how long might it realistically be before I could actually enroll, and is waiting a good idea given where I am in my recovery from my heart attack?
2This study is comparing arm-and-leg combined exercise machines to standard cycling — given my current physical condition after my myocardial infarction, is one of those approaches already recommended for me, or would participating in this comparison make sense?
3The trial is measuring cardiorespiratory fitness and quality of life as its main outcomes — are those the most important goals for my recovery right now, or are there other priorities my care team would focus on first?
4Since this trial is listed as phase 'NA' and seems to be a rehabilitation study rather than a drug trial, what do we already know about the safety of combined arm-leg ergometer training for someone in my specific situation after a heart attack?
5Would starting a standard cardiac rehabilitation program now make more sense for me than waiting for this trial to open, or could I potentially do both?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
cardiorespiratory fitness
Timeframe: Baseline and after 6 weeks of intervention
2
exercise tolerance
Timeframe: Baseline and after 6 weeks of intervention
3
individual quality of life
Timeframe: Baseline and after 6 weeks of intervention